Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients

Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks

(2018) Bharathi S. Gadad et al.   JOURNAL OF AFFECTIVE DISORDERS

Microglial control of astrocytes in response to microbial metabolites

(2018) Veit Rothhammer et al.   NATURE

Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics

(2018) Duan Liu et al.   Translational Psychiatry

Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategies

(2018) Kieu Trinh Do et al.   Metabolomics

Methylation Status of the Serotonin Transporter Promoter CpG Island Is Associated With Major Depressive Disorder in Chinese Han Population

(2017) Mei Shi et al.   JOURNAL OF NERVOUS AND MENTAL DISEASE

Feedback control of AHR signalling regulates intestinal immunity

(2017) Chris Schiering et al.   NATURE

Exploratory graph analysis: A new approach for estimating the number of dimensions in psychological research

(2017) Hudson F. Golino et al.   PLoS One

Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway

(2016) Enrico Cocchi et al.   BMC Psychiatry

TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics

(2016) M Gupta et al.   MOLECULAR PSYCHIATRY

Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor

(2016) Veit Rothhammer et al.   NATURE MEDICINE

Purine metabolism is dysregulated in patients with major depressive disorder

(2016) Toni Ali-Sisto et al.   PSYCHONEUROENDOCRINOLOGY

Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study

(2016) Naama Karu et al.   BMC Nephrology

Purine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans

(2016) Dong Ik Park et al.   Scientific Reports

Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants

(2016) D M Rotroff et al.   Translational Psychiatry

Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine

(2015) R Kaddurah-Daouk et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies

(2015) Gislaine Z. Réus et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A global reference for human genetic variation

(2015) Richard A. Gibbs et al.   NATURE

The role of the kynurenine pathway in suicidality in adolescent major depressive disorder

(2015) Kailyn A.L. Bradley et al.   PSYCHIATRY RESEARCH

Second-generation PLINK: rising to the challenge of larger and richer datasets

(2015) Christopher C Chang et al.   GigaScience

Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations

(2014) Yuan Ji et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Hydroxybenzoic acids and their derivatives as peroxynitrite scavengers

(2014) Beáta Hubková et al.   FREE RADICAL BIOLOGY AND MEDICINE

Uric acid levels may be a biological marker for the differentiation of unipolar and bipolar disorder: The role of affective temperament

(2014) Sermin Kesebir et al.   JOURNAL OF AFFECTIVE DISORDERS

Treatment Outcomes of Depression

(2014) David A. Mrazek et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

An atlas of genetic influences on human blood metabolites

(2014) So-Youn Shin et al.   NATURE GENETICS

The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease

(2014) Marion Sallée et al.   Toxins

Purine Pathway Implicated in Mechanism of Resistance to Aspirin Therapy: Pharmacometabolomics-Informed Pharmacogenomics

(2013) L M Yerges-Armstrong et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology

(2013) R Kaddurah-Daouk et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Antimicrobial peptides and gut microbiota in homeostasis and pathology

(2013) Maureen J. Ostaff et al.   EMBO Molecular Medicine

Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein

(2013) Wendy R. Russell et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Deficiency of Asparagine Synthetase Causes Congenital Microcephaly and a Progressive Form of Encephalopathy

(2013) Elizabeth K. Ruzzo et al.   NEURON

Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment

(2013) William R. Wikoff et al.   PLoS One

Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway

(2013) Hongjie Zhu et al.   PLoS One

Improved whole-chromosome phasing for disease and population genetic studies

(2012) Olivier Delaneau et al.   NATURE METHODS

Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans

(2012) Marco Orrú et al.   NEUROPHARMACOLOGY

Diet and Intestinal Immunity

(2012) Herbert Tilg   NEW ENGLAND JOURNAL OF MEDICINE

Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile

(2012) Rima Kaddurah-Daouk et al.   Scientific Reports

Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data

(2011) Jan Krumsiek et al.   BMC Systems Biology

Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation

(2011) Ying Li et al.   CELL

Serum uric acid levels and the clinical characteristics of depression

(2011) Shenglin Wen et al.   CLINICAL BIOCHEMISTRY

Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1

(2011) Bjoern O. Schroeder et al.   NATURE

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept

(2011) R Kaddurah-Daouk et al.   Translational Psychiatry

Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics

(2010) Y Ji et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The possible role of the kynurenine pathway in adolescent depression with melancholic features

(2010) Vilma Gabbay et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

Uremic toxins originating from colonic microbial metabolism

(2009) Pieter Evenepoel et al.   KIDNEY INTERNATIONAL

A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies

(2009) Bryan N. Howie et al.   PLoS Genetics

Metabolomics: A Global Biochemical Approach to Drug Response and Disease

(2008) Rima Kaddurah-Daouk et al.   Annual Review of Pharmacology and Toxicology

Selecting Among Second-Step Antidepressant Medication Monotherapies

(2008) A. John Rush et al.   ARCHIVES OF GENERAL PSYCHIATRY

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

(2008) IM Anderson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases

(2008) Rima Kaddurah-Daouk et al.   NEUROPSYCHOPHARMACOLOGY

Uric Acid: The Oxidant-Antioxidant Paradox

(2008) Yuri Y. Sautin et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS